Specific HCV NS3 protease inhibitors
US8729014B2 · kind B2 · utility
1Cited by
8References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 28, 2011 |
| Grant date | May 20, 2014 |
| Priority date | — |
| Expiry date | Aug 14, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to compounds, compositions and methods for treating or preventing viral infections, in particular, HCV in human patients or other animal hosts.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.